{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-057732","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.311260+00:00","generated_at":"2026-06-09T01:30:19.563311+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pediatrix Q3 GAAP EPS $0.26, Adjusted EPS $0.32; FY guidance $200-210M","bullets":["Q3 GAAP EPS $0.26 vs $0.35 YoY; Adjusted EPS $0.32 vs $0.40.","Net revenue $506.6M (+3.4% YoY) but same-unit patient volume declined 1.2%.","Adjusted EBITDA $50.4M, down 13.5% from $58.3M; practice costs rose to $368.4M.","FY2023 Adjusted EBITDA guidance $200-210M; first nine months $149.6M implies soft Q4.","Terminated R1 RCM contract effective Dec 15, 2023; plans hybrid revenue cycle model."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-057732","json":"https://secwatch.observer/filing/0000950170-23-057732.json","markdown":"https://secwatch.observer/filing/0000950170-23-057732.md","text":"https://secwatch.observer/filing/0000950170-23-057732.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/md-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T01:30:19.563311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5271777e13fcf45546f1b6abdfce1195212577d5","claim":"Pediatrix Medical Group, Inc. reported financial results for three months ended September 30, 2023.","evidence_excerpt":"On November 2, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2023 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"562251ed452df3709191ac278181f226ba3c116b","claim":"Pediatrix Medical Group, Inc. reported financial results for nine months ended September 30, 2023.","evidence_excerpt":"On November 2, 2023, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three months and nine months ended September 30, 2023 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine months ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}